Examples of using Acomplia in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
How does ACOMPLIA work?
ACOMPLIA 20 mg film-coated tablets.
How to store ACOMPLIA.
ACOMPLIA tablets include lactose.
HOW TO STORE ACOMPLIA lp.
ACOMPLIA 20 mg film-coated tablets.
Other information about ACOMPLIA.
D ACOMPLIA 20 mg film-coated tablets.
Ra What is the risk associated with ACOMPLIA?
Why has ACOMPLIA been approved?
EUROPEAN PUBLIC ASSESSMENT REPORT(epar) ACOMPLIA.
ACOMPLIA 20 mg film-coated tablets.
Further information WHAT ACOMPLIA IS AND WHAT IT IS USED FOR.
ACOMPLIA should not be taken during pregnancy.
Or What benefit has ACOMPLIA shown during the studies?
ACOMPLIA has not been shown to alter laboratory test values.
BEFORE YOU TAKE ACOMPLIA Do not take ACOMPLIA.
ACOMPLIA is a medicine containing the active substance rimonabant.
The Committee recommended that ACOMPLIA be given marketing authorisation. du.
ACOMPLIA is taken as one tablet once a day, before breakfast.
Ise their physician if they become pregnant during treatment with ACOMPLIA.
Therefore, ACOMPLIA is not recommended as an aid for smoking cessation.
Important information about some of the ingredients of ACOMPLIA ACOMPLIA tablets include lactose.
Generally ACOMPLIA 20 mg had no significant effect on Total-C or LDL-C levels.
Zevert(Betahistine) can be taken with Cannabinoid-1 Receptor Blockers(Rimonabant/Acomplia), Sibutramide hydrochloride(Meridia) and Orlistat Xenical.
ACOMPLIA 20 mg has been evaluated for safety in approximately 2500 patients enrolled in studies.
Significant mean weight reductions from baseline to one year for ACOMPLIA 20 mg versus placebo were demonstrated in three studies conducted in non-diabetic patients.
ACOMPLIA should be used with caution in patients with moderate hepatic impairment.
Contact your doctor immediately if you become pregnant, think you might be pregnant orare planning to become pregnant while taking ACOMPLIA.
Rimonabant(Acomplia) has been approved in the European Union(EU) since June 2006 for the treatment of obesity.